Skip to content
ApprovedFDA approved

Nebivolol (Nebilet, Bystolic)

Prescription beta-blocker for high blood pressure that also widens the blood vessels, so it causes less tiredness than classic beta-blockers.

Available at
DEUSPOWER logo
DEUSPOWERProduct page

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Nebivolol (Nebilet, Bystolic) vial

DETAILED OVERVIEW

What is Nebivolol (Nebilet, Bystolic)?

Nebivolol is a prescription medicine and a beta-blocker, a drug that eases the workload of the heart. It is widely approved for high blood pressure, and in Europe also for stable, mild to moderate heart failure in older people.

It works in two ways: it slows the heartbeat, and by releasing nitric oxide it also widens the blood vessels. Thanks to this widening effect, it causes less tiredness, cold hands and feet and erectile dysfunction than classic beta-blockers. In a large study of older people with heart failure, deaths or hospital stays for heart and circulation problems became less frequent. Tiredness and dizziness may appear at the start of treatment, and the heartbeat can slow too much. Stopping it suddenly can trigger chest pain (angina) or an irregular heartbeat. It must not be given in severe liver damage or in worsening heart failure. Because it is broken down by a liver enzyme that varies genetically, in slow metabolisers the blood level can be many times higher and the side effects stronger.

Dual action

Strong beta1-selective blockade plus nitric-oxide-mediated vasodilation.

Why better tolerated

The vasodilatory component offsets the cold extremities and fatigue typical of beta-blockers.

Outcome data

Elderly people with heart failure had fewer deaths or cardiovascular hospital stays

Genetic variability

CYP2D6-dependent: bioavailability ranges from 12% to 96% by metaboliser status.

Data console

Lab data

ATC code-
PrescriptionN/A
MechanismNebivolol acts in two independent ways. First, it is a…
Half-lifeAbout 10 hours in extensive CYP2D6 metabolisers and several times longer, above 30 hours, in poor metabolisers. Once-daily dosing suffices in both cases.
OnsetThe antihypertensive effect is noticeable within days, with the full effect over one to two weeks. In heart failure titration takes weeks.
BioavailabilityExtremely genotype-dependent: about 12% in extensive CYP2D6 metabolisers and up to 96% in poor metabolisers. This nearly eightfold difference is nebivolol's most important pharmacokinetic feature and explains why the same dose produces a substantially stronger effect and more adverse effects in some patients.

Safety

Side effects, stop signs, contraindications

Side effects · 4

  • Fatigue and dizziness: familiar beta-blocker complaints, but typically milder with nebivolol than with classic agents because of the vasodilatory action.
  • Slowing heart rate: an intrinsic part of the effect, but excessive bradycardia requires dose reduction. A resting pulse below 50 needs medical assessment.
  • Headache and peripheral edema: consequences of the vasodilatory component, usually mild.
  • In slow CYP2D6 metabolisers plasma levels can be many times the usual, so adverse effects are more pronounced. This is roughly 7-10% of people of European ancestry.

Contraindications · 4

  • Decompensated heart failure, cardiogenic shock, second or third degree AV block, sick sinus syndrome and severe bradycardia: absolute contraindications.
  • Severe hepatic impairment: clearance slows substantially, contraindicated.
  • Asthma and severe obstructive lung disease: beta1 selectivity is high but not absolute, so caution or avoidance is warranted.
  • Abrupt discontinuation: beta-blockers must be tapered, as sudden cessation can provoke angina or arrhythmia.

Related Pharmaceuticals

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about Nebivolol (Nebilet, Bystolic)?

Educational drug info from official sources (PubMed, FDA, EMA). Does NOT replace medical consultation or the SmPC. Talk to your doctor!

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is for educational and scientific purposes only. Medication use requires medical consultation and a prescription. The indications, dose ranges, and side effects listed here do NOT replace the official Summary of Product Characteristics (SmPC) or consultation with a physician. Do not start or stop any medication on your own. In an emergency, call your local emergency number.